Compare DRTS & MCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | MCS |
|---|---|---|
| Founded | 2015 | 1935 |
| Country | Israel | United States |
| Employees | 121 | N/A |
| Industry | Medical/Dental Instruments | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 641.6M | 541.6M |
| IPO Year | N/A | 1994 |
| Metric | DRTS | MCS |
|---|---|---|
| Price | $10.03 | $17.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.67 | ★ $23.33 |
| AVG Volume (30 Days) | ★ 698.4K | 118.2K |
| Earning Date | 05-18-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.69% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $758,458,000.00 |
| Revenue This Year | N/A | $12.05 |
| Revenue Next Year | $699.98 | $3.15 |
| P/E Ratio | ★ N/A | $22.49 |
| Revenue Growth | N/A | ★ 3.11 |
| 52 Week Low | $2.81 | $12.85 |
| 52 Week High | $10.81 | $20.02 |
| Indicator | DRTS | MCS |
|---|---|---|
| Relative Strength Index (RSI) | 64.43 | 49.33 |
| Support Level | $6.59 | $14.87 |
| Resistance Level | N/A | $17.92 |
| Average True Range (ATR) | 0.84 | 0.64 |
| MACD | 0.22 | -0.11 |
| Stochastic Oscillator | 78.69 | 39.02 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.